TILLMAN GERNGROSS is the CEO and co-founder of antibody discovery firm Adimab,
which does not fit the usual profile in biotech: it is self-sustaining, profitable,
and privately held. That unusual path, combined with the in-your-face gusto
Gerngross has become known for, has helped earn the outspoken Gerngross—
a biochemical engineer by training, a Dartmouth professor, and a serial biotech
entrepreneur—a spot on our list of contrarian finalists.
Tillman Gerngross, Adimab and Dartmouth College • Photography by Alex Gagne and Rythum Vinoben